EP 0920417 A4 19991229 - IL-8 RECEPTOR ANTAGONISTS
Title (en)
IL-8 RECEPTOR ANTAGONISTS
Title (de)
IL-8 REZEPTOR ANTAGONISTEN
Title (fr)
ANTAGONISTES DU RECEPTEUR DE L'IL-8
Publication
Application
Priority
- US 9714595 W 19970815
- US 2398996 P 19960815
- US 2399096 P 19960815
Abstract (en)
[origin: WO9806701A1] This invention relates to novel compounds of Formula (I), pharmaceutical compositions and their use in the treatment of disease states mediated by the chemokine, Interleukin-8 (IL-8).
IPC 1-7
C07D 223/16; C07D 235/06; C07D 333/52; A61K 31/38; A61K 31/415; A61K 31/55
IPC 8 full level
A61K 31/381 (2006.01); A61K 31/4184 (2006.01); A61K 31/55 (2006.01); A61P 7/02 (2006.01); A61P 11/06 (2006.01); A61P 17/00 (2006.01); A61P 19/02 (2006.01); A61P 25/28 (2006.01); C07D 223/16 (2006.01); C07D 235/06 (2006.01); C07D 235/08 (2006.01); C07D 333/54 (2006.01)
CPC (source: EP)
A61P 7/02 (2017.12); A61P 11/06 (2017.12); A61P 17/00 (2017.12); A61P 19/02 (2017.12); A61P 25/28 (2017.12); C07D 223/16 (2013.01); C07D 235/06 (2013.01); C07D 333/54 (2013.01)
Citation (search report)
- [A] US 5290814 A 19940301 - JACKSON WILLIAM P [GB], et al
- [A] US 5011837 A 19910430 - ATWAL KARNAIL [US], et al
- See references of WO 9806701A1
Designated contracting state (EPC)
AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 9806701 A1 19980219; EP 0920417 A1 19990609; EP 0920417 A4 19991229; JP 2001501172 A 20010130
DOCDB simple family (application)
US 9714595 W 19970815; EP 97939455 A 19970815; JP 51011098 A 19970815